UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

mTOR in Human Diseases

International journal of molecular sciences, 2019-05, Vol.20 (9), p.2351

Dormond, Olivier

2019

Volltextzugriff (PDF)

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment

Cancers, 2021-03, Vol.13 (6), p.1359

2021

Volltextzugriff (PDF)

Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma

Scientific reports, 2019-05, Vol.9 (1), p.7103, Article 7103

2019

Volltextzugriff (PDF)

mTOR in Human Diseases

Dormond, Olivier

2019

Volltextzugriff (PDF)

The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication

Cancers, 2021-02, Vol.13 (4), p.659

2021

Volltextzugriff (PDF)

Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?

International journal of molecular sciences, 2022-05, Vol.23 (10), p.5343

2022

Volltextzugriff (PDF)

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives

Frontiers in cell and developmental biology, 2021-03, Vol.9, p.636037-636037

2021

Volltextzugriff (PDF)

Carcinogenic effect of arsenic in digestive cancers: a systematic review

Environmental health, 2023-04, Vol.22 (1), p.36-36, Article 36

2023

Volltextzugriff (PDF)

mTOR and Tumor Cachexia

International journal of molecular sciences, 2018-07, Vol.19 (8), p.2225

2018

Volltextzugriff (PDF)

Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.257-257, Article 257

2019

Volltextzugriff (PDF)

Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib

Molecular cancer, 2011-07, Vol.10 (1), p.90-90, Article 90

2011

Volltextzugriff (PDF)

Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells

International journal of molecular sciences, 2021-06, Vol.22 (12), p.6467

2021

Volltextzugriff (PDF)

Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study

World journal of surgery, 2021-08, Vol.45 (8), p.2546-2555

2021

Volltextzugriff (PDF)

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Frontiers in oncology, 2022-08, Vol.12, p.940473-940473

2022

Volltextzugriff (PDF)

Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets

Cancers, 2021-05, Vol.13 (11), p.2551

2021

Volltextzugriff (PDF)

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells

EBioMedicine, 2016-02, Vol.4 (C), p.50-61

2016

Volltextzugriff (PDF)

Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study

PloS one, 2017-07, Vol.12 (7), p.e0180437-e0180437

2017

Volltextzugriff (PDF)

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma

Cancers, 2021-08, Vol.13 (16), p.3978

2021

Volltextzugriff (PDF)

Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells

BMC cancer, 2012-03, Vol.12 (1), p.86-86, Article 86

2012

Volltextzugriff (PDF)

Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy

Swiss medical weekly, 2017-10, Vol.147 (4142), p.w14517

2017

Volltextzugriff (PDF)

Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease

Life (Basel, Switzerland), 2023-05, Vol.13 (5), p.1213

2023

Volltextzugriff (PDF)

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

Cancers, 2011-05, Vol.3 (2), p.2478-2500

2011

Volltextzugriff (PDF)

Drug-Eluting Beads Loaded with Antiangiogenic Agents for Chemoembolization: In Vitro Sunitinib Loading and Release and In Vivo Pharmacokinetics in an Animal Model

Journal of vascular and interventional radiology, 2014-03, Vol.25 (3), p.379-387.e2

2014

Volltextzugriff (PDF)

Thoracic Aortic Dilation/Aneurysm in Fabry Disease

The American journal of medicine, 2013-12, Vol.126 (12), p.e23-e23

2013

Volltextzugriff (PDF)

Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment

Cancers, 2020-09, Vol.12 (9), p.2697

2020

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Aktive Filter

SpracheJapanisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(73)

Publikationsform

Artikel
(85)
Bücher
(1)

Sprache

Englisch
(84)
Französisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(49)
Humans
(35)
Animals
(22)
Cancer
(16)
Mtor
(15)
Oncology
(15)
Biochemistry & Molecular Biology
(12)
Mice
(12)
Rapamycin
(12)
Angiogenesis
(11)
Cell Line, Tumor
(11)
Female
(11)
Apoptosis
(9)
Kinases
(9)
Signal Transduction
(9)
Tor Serine-Threonine Kinases - Antagonists & Inhibitors
(9)
Tumors
(9)
Cells, Cultured
(8)
Biological And Medical Sciences
(7)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

mTOR in Human Diseases

Combining mTOR Inhibitors and T Cell-Based Immunotherapies in Cancer Treatment

Short-term 3D culture systems of various complexity for treatment optimization of colorectal carcinoma

mTOR in Human Diseases

The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication

Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?

Mechanistic Target of Rapamycin Inhibitors in Renal Cell Carcinoma: Potential, Limitations, and Perspectives

Carcinogenic effect of arsenic in digestive cancers: a systematic review

mTOR and Tumor Cachexia

Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8+ T cells

Targeting renal cell carcinoma with NVP-BEZ235, a dual PI3K/mTOR inhibitor, in combination with sorafenib

Molecular and Functional Analysis of Sunitinib-Resistance Induction in Human Renal Cell Carcinoma Cells

Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?

Characterization of Renal Cell Carcinoma Heterotypic 3D Co-Cultures with Immune Cell Subsets

Modulation of mTOR Signalling Triggers the Formation of Stem Cell-like Memory T Cells

Long-term follow-up of pulmonary function in Fabry disease: A bi-center observational study

Drug Repurposing to Identify a Synergistic High-Order Drug Combination to Treat Sunitinib-Resistant Renal Cell Carcinoma

Antitumor activities of ATP-competitive inhibitors of mTOR in colon cancer cells

Ascending aortic remodelling in Fabry disease after long-term enzyme replacement therapy

Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease

Targeting the Mammalian Target of Rapamycin (mTOR) in Cancer Therapy: Lessons from Past and Future Perspectives

Drug-Eluting Beads Loaded with Antiangiogenic Agents for Chemoembolization: In Vitro Sunitinib Loading and Release and In Vivo Pharmacokinetics in an Animal Model

Thoracic Aortic Dilation/Aneurysm in Fabry Disease

Integrating Phenotypic Search and Phosphoproteomic Profiling of Active Kinases for Optimization of Drug Mixtures for RCC Treatment

Aktive Filter

Suchergebnisse filtern